Followers | 85 |
Posts | 6167 |
Boards Moderated | 0 |
Alias Born | 05/27/2009 |
Thursday, January 07, 2021 2:46:58 PM
I was tired of this sitting, and expecting a pull back market wide so sold 750 shares at 2:08pm today 1/7 for $34.82 at $1.10 loss per share...
I blink my eye & within 40 minutes its over $42 ? !!!
Recent GLSI News
- Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe • GlobeNewswire Inc. • 03/12/2024 10:00:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/07/2024 02:41:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:05:19 AM
- Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators • GlobeNewswire Inc. • 02/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:05:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 11:04:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:10:47 PM
- Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 • GlobeNewswire Inc. • 02/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:15:23 PM
- Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 • GlobeNewswire Inc. • 11/21/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2023 11:05:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2023 11:15:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 10:15:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2023 10:15:23 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/25/2023 08:15:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/19/2023 08:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 10:05:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 10:05:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2023 10:05:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 10:05:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 10:05:45 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM